학술논문

Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 6 March 2020, 10)
Subject
Language
English
ISSN
2234943X